Aurobindo Pharma Ltd (524804) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Aurobindo Pharma Ltd Company Snapshot

Business Description:

Aurobindo Pharma Ltd operates in the Pharmaceutical preparations sector. Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage formulations. The Company's product portfolio consists of seven therapeutic/product areas, which includes antibiotics, anti-retrovirals, cardiovascular system (CVS), central nervous system (CNS), gastroenterologicals, anti-diabetics and anti-allergics. The Company markets its products in over 125 countries. Its products portfolio consists of more than 300 products. The Company's products include Ramipril, Trandolapril and Benazepril Hydrochloride. Its therapeutic segments include semi-synthetic penicillins (SSPs), cephalosporins, antivirals, CNS, cardio-vascular and gastroenterology. In our complete report available for purchase the company is compared to: Cadila Healthcare Ltd, Wockhardt Limited and Cipla Ltd.

Aurobindo Pharma Ltd

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 120.40
(Figures in Indian Rupees)

1 Week	6.5%	13 Weeks	34.1%

4 Weeks	-6.2%	52 Weeks	-48.7%

Aurobindo Pharma Ltd Key Data:

Ticker:	524804	Country:	INDIA

Exchanges:	BOM	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2011 Sales	43,180,300,000 (Year Ending Jan 2012).	Employees:	8,317

Currency:	Indian Rupees	Market Cap:	35,051,003,316

Fiscal Yr Ends:	March	Shares Outstanding:	291,121,290

Share Type:	Ordinary	Closely Held Shares:	158,284,800

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.